Odile Siffert

Title: Odile Siffert: Innovator in Synthetic Peptide Research

Introduction

Odile Siffert is a notable inventor based in Versailles, France. She has made significant contributions to the field of synthetic peptides, particularly in the development of novel medicaments for treating cholera and infectious gastro-enteritis. With a total of 2 patents, her work has the potential to impact public health positively.

Latest Patents

Siffert's latest patents focus on a synthetic peptide that reproduces at least five of the eleven amino acids common to the gamma chain of sub-unit A of cholera toxin and the gamma chain of LT toxin of Escherichia coli. The invention details a pentadecapeptide synthesized through a step-by-step construction process, starting from the C-terminal end of the peptide chain. This innovative peptide serves as an active constituent in a novel medicament designed for the treatment of cholera and infectious gastro-enteritis. Additionally, a diagnostic agent for cholera and/or infectious gastro-enteritis is also described, which comprises a sequence of nucleotides corresponding to the minimum five amino acids of the synthetic peptide.

Career Highlights

Odile Siffert is affiliated with the Institut Pasteur, a prestigious research institution known for its contributions to microbiology and immunology. Her work at this institution has allowed her to focus on groundbreaking research in synthetic peptides and their applications in medicine.

Collaborations

Siffert has collaborated with notable colleagues, including Andre Dodin and Georgette Le Thuillier, who have contributed to her research endeavors.

Conclusion

Odile Siffert's innovative work in synthetic peptides represents a significant advancement in medical research, particularly in the fight against cholera and infectious diseases. Her contributions continue to pave the way for new therapeutic options and diagnostic tools.